Published online May 27, 2025. doi: 10.4240/wjgs.v17.i5.101047
Revised: February 22, 2025
Accepted: March 19, 2025
Published online: May 27, 2025
Processing time: 132 Days and 18.3 Hours
Gastric cancer is a malignancy with high morbidity and mortality rates. Surgical intervention, particularly gastrectomy, is essential for curative treatment but carries a substantial risk of complications. Identifying key risk factors and under
To analyze the incidence of postoperative complications in patients with gastric cancer and identify potential risk factors.
We conducted a retrospective analysis of 500 patients who underwent gastre
The overall complication rate was 28.4% (142/500), with 15.2% (76/500) experiencing major complications (Clavien-Dindo grade ≥ III). Pulmonary complications were the most frequent (10.8%), followed by surgical site infections (8.6%), and anastomotic leakage (4.2%). Age 70 years or more, body mass index of 25 kg/m² or more, advanced tumor stage, total gastrectomy, and operative time 240 min or more emerged as independent risk factors.
Focused preoperative risk assessment, targeted interventions, and reduced operative time for older or obese patients requiring total gastrectomy or presenting with advanced disease are important to improve surgical outcomes.
Core Tip: This retrospective study examined 500 patients with gastric cancer undergoing gastrectomy and revealed an overall complication rate of 28.4 %, with 15.2% experiencing major complications. Key risk factors identified include age 70 years or more, body mass index of 25 kg/m² or more, advanced tumor stage, total gastrectomy, and prolonged operative time. Utilizing the Clavien-Dindo classification highlights the importance of identifying high-risk patients to implement targeted interventions, ultimately aiming to reduce complication rates and improve surgical outcomes in this vulnerable population.
- Citation: Xiao Y, Ren BC, Zhang T, Peng D, Min J. Factors influencing postoperative complications in patients with gastric cancer: A retrospective study. World J Gastrointest Surg 2025; 17(5): 101047
- URL: https://www.wjgnet.com/1948-9366/full/v17/i5/101047.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i5.101047
Gastric cancer is the fifth most common cancer and the third leading cause of cancer-related deaths worldwide, with an estimated 1089103 new cases and 768793 deaths in 2020[1]. Despite advancements in diagnostic techniques and treatment modalities, the prognosis of patients with gastric cancer remains poor, particularly for those with advanced stages[2]. Surgical resection remains the cornerstone of curative treatment for gastric cancer and is often combined with perioperative or adjuvant chemotherapy in advanced cases[3].
Existing research indicates that postoperative complications following gastric cancer surgery significantly affect patient survival, prolong hospital stay, and delay adjuvant therapy[4]. The reported complication rates vary widely from 10% to 46%, partly because of heterogeneous definitions and classification systems[5,6]. Moreover, factors such as age, nutritional status, tumor stage, and operative time have been implicated in predicting adverse outcomes; however, there is variability across studies[7]. Several factors have been suggested to influence the risk of postoperative complications, including patient-related (e.g., age, comorbidities, and nutritional status), tumor-related (e.g., tumor stage and location), and treatment-related factors (e.g., extent of resection and operative time)[8,9].
However, the relative impact of these factors and their interplay in determining the risk of complications remains unclear. Moreover, most previous studies have focused on specific complications or have used varying definitions and classification systems, making comparisons and generalizations challenging[10]. Comprehensive studies using stan
The Clavien-Dindo classification system has emerged as a widely accepted and validated tool for grading surgical complications[11]. This system categorizes complications based on the type of therapy required to treat them and provides a more objective and reproducible assessment of surgical morbidity. This standardized system facilitates more meaningful comparisons across studies and institutions.
Nevertheless, challenges remain. The precise interplay between the risk factors has not been exhaustively explored in large and diverse patient cohorts. To address these gaps, we applied the standardized Clavien-Dindo classification to a relatively large retrospective cohort of 500 patients with gastric cancer. This approach ensures comparability with other studies and highlights the potential risk factors for targeted preventive strategies.
Hence, the objectives of our study were to ascertain the incidence and spectrum of postoperative complications using the Clavien-Dindo classification, to identify independent risk factors linked to these complications, and to discuss how these findings might guide personalized perioperative management, including tailored follow-up and risk-based operative planning, and to better define the risk profiles of patients undergoing gastrectomy to optimize perioperative protocols and allocate resources to high-risk individuals, ultimately aiming to reduce morbidity and enhance survival outcomes.
We conducted a retrospective cohort study of patients who underwent gastrectomy for gastric cancer at the First Affiliated Hospital of Chongqing Medical University, a high-volume tertiary care center, between January 1, 2018, and December 31, 2022. The study protocol was approved by the Institutional Review Board of the First Affiliated Hospital of Chongqing Medical University, and the need for informed consent was waived because of the retrospective nature of the study.
Inclusion criteria were: (1) Histologically confirmed gastric adenocarcinoma; (2) Age 18 years or more; and (3) Curative-intent gastrectomy (total or subtotal) with lymph node dissection. The exclusion criteria were: (1) Palliative surgery; (2) Emergency surgery; (3) Concurrent malignancy; and (4) Incomplete medical records.
Patient data were extracted from electronic medical records and a prospectively maintained institutional database. The collected information included patient characteristics such as age, sex, body mass index (BMI), American Society of Anesthesiologists physical status classification, comorbidities, smoking history, and preoperative laboratory values. Tumor characteristics including location, clinical tumor node metastasis stage, and histological type were also recorded. The treatment details included neoadjuvant therapy, type of gastrectomy, extent of lymph node dissection, combined organ resection, operative time, estimated blood loss, and volume of blood transfusion. Postoperative outcomes, in
Postoperative complications were defined as any deviation from the normal postoperative course within 30 days of surgery or during hospitalization. All complications were graded according to the Clavien-Dindo classification system[11]. This system categorizes complications based on the type of therapy required to treat the complication: Grade I: Any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic, or radiological interventions; Grade II: Requires pharmacological treatment with drugs other than those allowing for grade I complications; Grade III: Requiring surgical, endoscopic, or radiological intervention; Grade IV: Life-threatening complication requiring intensive care or intensive care unit management; Grade V: Death of a patient.
Major complications were defined as Clavien-Dindo grade III or higher. In cases where a patient experienced multiple complications, the highest grade was used for analysis.
Specific complications were also recorded, including pulmonary complications (pneumonia, atelectasis requiring intervention, pleural effusion requiring drainage), cardiovascular complications (myocardial infarction, arrhythmia requiring intervention, pulmonary embolism), surgical site infections (classified as superficial incisional, deep incisional, or organ/space according to the centers for disease control and prevention criteria), anastomotic leakage (confirmed by radiological imaging or reoperation), pancreatic fistula (defined and graded according to the International Study Group of Pancreatic Fistula criteria), postoperative bleeding (requiring transfusion or reoperation), and delayed gastric emptying (requiring nasogastric tube reinsertion after postoperative day 3 or inability to tolerate oral intake by postoperative day 7).
Continuous variables are expressed as mean ± SD or median (interquartile range), depending on the distribution of data. Categorical variables are presented as frequencies and percentages. The Shapiro-Wilk test was used to assess the normality of continuous variables.
Univariate analysis was performed to identify potential risk factors for postoperative complications. The χ2 test or Fisher’s exact test was used for categorical variables, and the student’s t-test or Mann-Whitney U test was used for continuous variables, as appropriate.
Variables with a P value < 0.1 in the univariate analysis were included in a multivariate logistic regression model to identify independent risk factors for postoperative complications. The results are presented as odds ratios (OR) with 95% confidence intervals (CI). The Hosmer-Lemeshow test was used to assess the goodness-of-fit of the logistic regression model.
All statistical analyses were performed using IBM SPSS Statistics for Windows (version 26.0; IBM Corp., Armonk, NY, United States). Statistical significance was defined as a two-sided P value of < 0.05.
A total of 500 patients who underwent gastrectomy for gastric cancer between January 2015 and December 2019 were included in this study. The mean age of the patients was 63.7 ± 11.2 years, and 312 (62.4%) were male. Baseline characteristics of the study population are summarized in Table 1.
Characteristic | Value |
Age (years) | 63.7 ± 11.2 |
Male sex | 312 (62.4) |
BMI (kg/m²) | 23.8 ± 3.6 |
ASA score | |
I | 98 (19.6) |
II | 276 (55.2) |
III | 118 (23.6) |
IV | 8 (1.6) |
Comorbidities | |
Hypertension | 187 (37.4) |
Diabetes | 95 (19.0) |
Cardiovascular disease | 73 (14.6) |
COPD | 41 (8.2) |
Smoking history | 156 (31.2) |
Preoperative laboratory values | |
Hemoglobin (g/dL) | 12.3 ± 1.8 |
Albumin (g/dL) | 3.8 ± 0.5 |
CRP (mg/L), median (IQR) | 5.2 (2.1-12.7) |
Tumor location | |
Upper third | 112 (22.4) |
Middle third | 178 (35.6) |
Lower third | 210 (42.0) |
Clinical TNM stage | |
I | 156 (31.2) |
II | 178 (35.6) |
III | 166 (33.2) |
Lauren classification | |
Intestinal | 247 (49.4) |
Diffuse | 193 (38.6) |
Mixed | 60 (12.0) |
Neoadjuvant therapy | 87 (17.4) |
The surgical characteristics of the study population are presented in Table 2.
Characteristic | Value |
Type of gastrectomy | |
Total | 187 (37.4) |
Subtotal | 313 (62.6) |
Combined organ resection | 68 (13.6) |
Operative time (minute), median (IQR) | 225 (185-270) |
Estimated blood loss (mL), median (IQR) | 200 (150-300) |
Intraoperative blood transfusion | 53 (10.6) |
The overall complication rate was 28.4% (142/500), with 15.2% (76/500) of patients experiencing major complications (Clavien-Dindo grade ≥ III). The distribution of complications according to the Clavien-Dindo classification is shown in Table 3. The most common types of complications are presented in Table 4.
Clavien-Dindo grade | n (%) |
No complications | 358 (71.6) |
I | 37 (7.4) |
II | 29 (5.8) |
IIIa | 42 (8.4) |
IIIb | 21 (4.2) |
IVa | 9 (1.8) |
IVb | 2 (0.4) |
V | 2 (0.4) |
Complication | n (%) |
Pulmonary complications | 54 (10.8) |
Surgical site infections | 43 (8.6) |
Anastomotic leakage | 21 (4.2) |
Pancreatic fistula | 18 (3.6) |
Postoperative bleeding | 15 (3.0) |
Delayed gastric emptying | 14 (2.8) |
Cardiovascular complications | 12 (2.4) |
Older patients (≥ 70 years) or had a BMI of 25 kg/m² or more showed a higher complication rate. Advanced tumor stage (especially stage III) also significantly increased the risk, presumably because of more extensive surgical procedures and compromised nutritional status. Total gastrectomy has a higher incidence of complications than subtotal resection, suggesting that complete stomach removal confers greater technical demands and physiological stress. Additionally, operations extending beyond 240 minutes were correlated with more frequent morbidity, indicating that prolonged intraoperative manipulation could exacerbate tissue trauma and hemodynamic fluctuations.
As shown in Table 5, multivariate logistic regression confirmed 5 independent predictors: Age 70 years or more (OR = 1.78, P = 0.003), BMI: 25 kg/m² or more (OR = 1.56, P = 0.027), advanced tumor stage (OR = 1.92, P = 0.001), total gastrectomy (OR = 1.75, P = 0.005), and operative time ≥ 240 minutes or more (OR = 1.63, P = 0.015).
Risk factor | Complication (n = 142) | No complication (n = 358) | Univariate P value | Multivariate OR (95%CI) | Multivariate P value |
Age ≥ 70 years | 58 (40.8) | 92 (25.7) | 0.001 | 1.78 (1.21-2.62) | 0.003 |
BMI ≥ 25 kg/m² | 51 (35.9) | 89 (24.9) | 0.015 | 1.56 (1.05-2.31) | 0.027 |
ASA score ≥ III | 52 (36.6) | 74 (20.7) | < 0.001 | Not identified | Not identified |
Diabetes | 37 (26.1) | 58 (16.2) | 0.012 | Not identified | Not identified |
Preop albumin < 3.5 g/dL | 45 (31.7) | 76 (21.2) | 0.015 | Not identified | Not identified |
Advanced tumor stage (III) | 62 (43.7) | 104 (29.1) | 0.002 | 1.92 (1.29-2.86) | 0.001 |
Total gastrectomy | 68 (47.9) | 119 (33.2) | 0.003 | 1.75 (1.18-2.59) | 0.005 |
Combined organ resection | 28 (19.7) | 40 (11.2) | 0.014 | Not identified | Not identified |
Operative time ≥ 240 minutes | 71 (50.0) | 129 (36.0) | 0.004 | 1.63 (1.10-2.42) | 0.015 |
Blood loss ≥ 300 mL | 53 (37.3) | 97 (27.1) | 0.026 | Not identified | Not identified |
The median length of hospital stay was 10 days (interquartile range: 8-14 days). Patients who experienced complications had significantly longer hospital stays than those without complications (median: 15 vs 9 days, P < 0.001).
The 30-day readmission rate was 7.2% (36/500), which was higher in patients who experienced complications than in those who did not (15.5% vs 3.9%, P < 0.001). The 30-day mortality rate was 0.4% (2/500), and the 90-day mortality rate was 1.2% (6/500).
This retrospective study of 500 patients who underwent gastrectomy for gastric cancer provided a comprehensive analysis of the postoperative complication rates and associated risk factors. Our findings contribute to the growing body of evidence on surgical outcomes of gastric cancer and offer insights into improving perioperative management and patient selection.
The overall complication rate in our study was 28.4%, with 15.2% of patients experiencing major complications (Clavien-Dindo grade ≥ III). These rates are consistent with those reported in recent literature, which range from 20% to 46%[12,13]. The variability in the reported complication rates can be attributed to differences in patient populations, surgical techniques, and complication definitions across studies. Our use of the standardized Clavien-Dindo classification system enhances the comparability of our results with those of other studies using this widely accepted grading system.
Pulmonary complications were the most frequent (10.8%), followed by surgical site infections (8.6%), and anastomotic leakage (4.2%). This distribution is similar to that reported in other large series[14,15]. The high incidence of pulmonary complications underscores the importance of optimizing preoperative pulmonary function and implementing aggressive postoperative pulmonary care protocols. Similarly, the notable rate of surgical site infections highlights the need for strict adherence to infection prevention measures and appropriate use of prophylactic antibiotics.
Our multivariate analysis identified five independent risk factors for postoperative complications: Age 70 years or more, BMI 25 kg/m² or more, advanced tumor stage, total gastrectomy, and operative time 240 minutes or more. These findings have important implications for preoperative risk assessment and perioperative management.
The increased risk of complications in older patients (OR = 1.78, 95%CI: 1.21-2.62) is consistent with previous studies[16,17]. This may be attributed to decreased physiological reserves, increased comorbidities, and reduced functional capacity in Elderly patients. Our findings emphasize the need for comprehensive geriatric assessment and optimization before surgery as well as tailored perioperative care for this vulnerable population.
The association between higher BMI and increased complication risk (OR = 1.56, 95%CI: 1.05-2.31) aligns with previous reports[18,19]. Obesity can complicate surgical techniques, prolong operative times, and impair wound healing. Preo
In addition to weight optimization, comprehensive preoperative evaluation is crucial. Recent research indicates that patients should undergo colonoscopy when diagnosed with gastric neoplasms, especially patients with gastric cancer, a low BMI, and a history of smoking[20]. This finding highlights the importance of thorough preoperative screening for potential comorbidities.
Patients with advanced-stage tumors had a higher risk of complications (OR = 1.92, 95%CI: 1.29-2.86). This may be due to more extensive surgery, poorer nutritional status, and systemic effects of advanced malignancy[21]. These findings underscore the importance of early detection and treatment of gastric cancer as well as the need for careful patient selection and preoperative optimization in advanced cases.
Furthermore, emerging evidence suggests that oral health may play a role in gastric cancer risk. A recent study reported that patients with poor oral health, especially those with periodontitis, have a higher risk of gastric cancer. Patients should be concerned about oral health. Improving oral health may reduce the risk of gastric cancer[22]. This underscores the importance of comprehensive health assessments and potential preventive strategies for gastric cancer management.
Total gastrectomy was associated with a higher complication risk compared to subtotal gastrectomy (OR = 1.75, 95%CI: 1.18-2.59). This is likely due to the more extensive nature of surgery, potentially longer operative times, and the physiological impact of complete gastric removal[23]. When oncologically appropriate, subtotal gastrectomy may help reduce complication rates in selected patients.
Prolonged operative time was an independent risk factor for complications (OR = 1.63, 95%CI: 1.10-2.42). This may reflect case complexity, technical difficulties, and surgeon experience[24]. Efforts to optimize surgical efficiency, such as standardized operative protocols and enhanced training programs, may help reduce operative time and associated complications.
These findings suggest personalized management strategies, such as prehabilitation for older patients or those with a high BMI, and a focus on nutrition and comorbidity optimization may prevent postoperative complications. Patients with advanced-stage gastric cancer require careful monitoring and conservative surgery. Patients undergoing total gas
These findings have important clinical implications. The identified risk factors can aid in more accurate preoperative risk assessment, facilitating informed decision-making and patient counseling. Targeted interventions for modifiable risk factors, such as preoperative nutritional support, prehabilitation programs for older patients, and weight optimization for patients with obesity, may help reduce complication rates. Moreover, recent evidence suggests that older patients with gastric cancer who received the enhanced recovery after surgery protocol after surgery had a lower risk of mortality[25]. The higher risk associated with total gastrectomy and the prolonged operative time underscores the importance of careful surgical planning and technique optimization. Moreover, by identifying high-risk patients, healthcare resources can be allocated more efficiently, potentially improving overall outcomes and reducing healthcare costs.
This study has several limitations. The retrospective nature of this study introduces the potential for selection bias and limits the ability to establish causal relationships. As this was a single-center study, our findings may not be generalizable to all populations or healthcare settings. Multicenter studies are required to validate these results. We focused on short-term postoperative outcomes, and future studies should assess the impact of complications on long-term oncological outcomes. Despite comprehensive data collection, there may have been unmeasured factors influencing complication rates that were not accounted for in our analysis. Lastly, over the study period, changes in surgical techniques or perioperative management may have influenced the complication rates.
In conclusion, by enhancing our understanding of the risk factors associated with postoperative complications in gastric cancer surgery, this study contributes to ongoing efforts to improve patient outcomes. The implementation of risk-stratified management strategies coupled with the continued refinement of surgical techniques and perioperative care protocols holds promise for reducing complication rates and improving overall outcomes in patients undergoing gastrectomy for gastric cancer.
1. | Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209-249. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 75126] [Cited by in RCA: 62353] [Article Influence: 15588.3] [Reference Citation Analysis (171)] |
2. | Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396:635-648. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 1150] [Cited by in RCA: 2716] [Article Influence: 543.2] [Reference Citation Analysis (5)] |
3. | Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer. 2021;24:1-21. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 735] [Cited by in RCA: 1295] [Article Influence: 323.8] [Reference Citation Analysis (2)] |
4. | Tohme S, Simmons RL, Tsung A. Surgery for Cancer: A Trigger for Metastases. Cancer Res. 2017;77:1548-1552. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 255] [Cited by in RCA: 460] [Article Influence: 57.5] [Reference Citation Analysis (0)] |
5. | Papenfuss WA, Kukar M, Oxenberg J, Attwood K, Nurkin S, Malhotra U, Wilkinson NW. Morbidity and mortality associated with gastrectomy for gastric cancer. Ann Surg Oncol. 2014;21:3008-3014. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 143] [Cited by in RCA: 175] [Article Influence: 15.9] [Reference Citation Analysis (0)] |
6. | Tu RH, Lin JX, Zheng CH, Li P, Xie JW, Wang JB, Lu J, Chen QY, Cao LL, Lin M, Huang CM. Development of a nomogram for predicting the risk of anastomotic leakage after a gastrectomy for gastric cancer. Eur J Surg Oncol. 2017;43:485-492. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 31] [Cited by in RCA: 23] [Article Influence: 2.9] [Reference Citation Analysis (0)] |
7. | Kurita N, Miyata H, Gotoh M, Shimada M, Imura S, Kimura W, Tomita N, Baba H, Kitagawa Y, Sugihara K, Mori M. Risk Model for Distal Gastrectomy When Treating Gastric Cancer on the Basis of Data From 33,917 Japanese Patients Collected Using a Nationwide Web-based Data Entry System. Ann Surg. 2015;262:295-303. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 95] [Cited by in RCA: 124] [Article Influence: 12.4] [Reference Citation Analysis (0)] |
8. | Park DJ, Lee HJ, Kim HH, Yang HK, Lee KU, Choe KJ. Predictors of operative morbidity and mortality in gastric cancer surgery. Br J Surg. 2005;92:1099-1102. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 190] [Cited by in RCA: 197] [Article Influence: 9.9] [Reference Citation Analysis (0)] |
9. | So JB, Yam A, Cheah WK, Kum CK, Goh PM. Risk factors related to operative mortality and morbidity in patients undergoing emergency gastrectomy. Br J Surg. 2000;87:1702-1707. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 50] [Cited by in RCA: 55] [Article Influence: 2.2] [Reference Citation Analysis (0)] |
10. | Baiocchi GL, Giacopuzzi S, Reim D, Piessen G, Costa PMD, Reynolds JV, Meyer HJ, Morgagni P, Gockel I, Santos LL, Jensen LS, Murphy T, D'Ugo D, Rosati R, Fumagalli Romario U, Degiuli M, Kielan W, Mönig S, Kołodziejczyk P, Polkowski W, Pera M, Schneider PM, Wijnhoven B, de Steur WO, Gisbertz SS, Hartgrink H, van Sandick JW, Botticini M, Hölscher AH, Allum W, De Manzoni G. Incidence and Grading of Complications After Gastrectomy for Cancer Using the GASTRODATA Registry: A European Retrospective Observational Study. Ann Surg. 2020;272:807-813. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 55] [Cited by in RCA: 47] [Article Influence: 9.4] [Reference Citation Analysis (0)] |
11. | Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-213. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 18532] [Cited by in RCA: 24437] [Article Influence: 1163.7] [Reference Citation Analysis (0)] |
12. | Lee KG, Lee HJ, Yang JY, Oh SY, Bard S, Suh YS, Kong SH, Yang HK. Risk factors associated with complication following gastrectomy for gastric cancer: retrospective analysis of prospectively collected data based on the Clavien-Dindo system. J Gastrointest Surg. 2014;18:1269-1277. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 86] [Cited by in RCA: 101] [Article Influence: 9.2] [Reference Citation Analysis (0)] |
13. | Selby LV, Vertosick EA, Sjoberg DD, Schattner MA, Janjigian YY, Brennan MF, Coit DG, Strong VE. Morbidity after Total Gastrectomy: Analysis of 238 Patients. J Am Coll Surg. 2015;220:863-871.e2. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 47] [Cited by in RCA: 57] [Article Influence: 5.7] [Reference Citation Analysis (0)] |
14. | Li ZY, Shan F, Zhang LH, Bu ZD, Wu AW, Wu XJ, Zong XL, Wu Q, Ren H, Ji JF. Complications after radical gastrectomy following FOLFOX7 neoadjuvant chemotherapy for gastric cancer. World J Surg Oncol. 2011;9:110. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 25] [Cited by in RCA: 34] [Article Influence: 2.4] [Reference Citation Analysis (0)] |
15. | Rosania R, Chiapponi C, Malfertheiner P, Venerito M. Nutrition in Patients with Gastric Cancer: An Update. Gastrointest Tumors. 2016;2:178-187. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 64] [Cited by in RCA: 78] [Article Influence: 8.7] [Reference Citation Analysis (0)] |
16. | Yamada H, Kojima K, Inokuchi M, Kawano T, Sugihara K. Effect of obesity on technical feasibility and postoperative outcomes of laparoscopy-assisted distal gastrectomy--comparison with open distal gastrectomy. J Gastrointest Surg. 2008;12:997-1004. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 64] [Cited by in RCA: 67] [Article Influence: 3.9] [Reference Citation Analysis (0)] |
17. | Kunisaki C, Makino H, Takagawa R, Sato K, Kawamata M, Kanazawa A, Yamamoto N, Nagano Y, Fujii S, Ono HA, Akiyama H, Shimada H. Predictive factors for surgical complications of laparoscopy-assisted distal gastrectomy for gastric cancer. Surg Endosc. 2009;23:2085-2093. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 75] [Cited by in RCA: 94] [Article Influence: 5.5] [Reference Citation Analysis (0)] |
18. | Verlato G, Marrelli D, Accordini S, Bencivenga M, Di Leo A, Marchet A, Petrioli R, Zoppini G, Muggeo M, Roviello F, de Manzoni G. Short-term and long-term risk factors in gastric cancer. World J Gastroenterol. 2015;21:6434-6443. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in CrossRef: 25] [Cited by in RCA: 22] [Article Influence: 2.2] [Reference Citation Analysis (0)] |
19. | Lee JH, Park DJ, Kim HH, Lee HJ, Yang HK. Comparison of complications after laparoscopy-assisted distal gastrectomy and open distal gastrectomy for gastric cancer using the Clavien-Dindo classification. Surg Endosc. 2012;26:1287-1295. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 80] [Cited by in RCA: 83] [Article Influence: 5.9] [Reference Citation Analysis (0)] |
20. | Liu XR, Wen ZL, Liu F, Li ZW, Liu XY, Zhang W, Peng D. Colonoscopy plays an important role in detecting colorectal neoplasms in patients with gastric neoplasms. World J Gastrointest Oncol. 2024;16:133-143. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Reference Citation Analysis (6)] |
21. | Sano T, Sasako M, Yamamoto S, Nashimoto A, Kurita A, Hiratsuka M, Tsujinaka T, Kinoshita T, Arai K, Yamamura Y, Okajima K. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501. J Clin Oncol. 2004;22:2767-2773. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 483] [Cited by in RCA: 486] [Article Influence: 23.1] [Reference Citation Analysis (0)] |
22. | Sulaiman Y, Pacauskienė IM, Šadzevičienė R, Anuzyte R. Oral and Gut Microbiota Dysbiosis Due to Periodontitis: Systemic Implications and Links to Gastrointestinal Cancer: A Narrative Review. Medicina (Kaunas). 2024;60:1416. [RCA] [PubMed] [DOI] [Full Text] [Reference Citation Analysis (0)] |
23. | Watanabe M, Miyata H, Gotoh M, Baba H, Kimura W, Tomita N, Nakagoe T, Shimada M, Kitagawa Y, Sugihara K, Mori M. Total gastrectomy risk model: data from 20,011 Japanese patients in a nationwide internet-based database. Ann Surg. 2014;260:1034-1039. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 116] [Cited by in RCA: 152] [Article Influence: 15.2] [Reference Citation Analysis (0)] |
24. | Kim W, Kim HH, Han SU, Kim MC, Hyung WJ, Ryu SW, Cho GS, Kim CY, Yang HK, Park DJ, Song KY, Lee SI, Ryu SY, Lee JH, Lee HJ; Korean Laparo-endoscopic Gastrointestinal Surgery Study (KLASS) Group. Decreased Morbidity of Laparoscopic Distal Gastrectomy Compared With Open Distal Gastrectomy for Stage I Gastric Cancer: Short-term Outcomes From a Multicenter Randomized Controlled Trial (KLASS-01). Ann Surg. 2016;263:28-35. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 389] [Cited by in RCA: 483] [Article Influence: 53.7] [Reference Citation Analysis (1)] |
25. | Li ZW, Luo XJ, Liu F, Liu XR, Shu XP, Tong Y, Lv Q, Liu XY, Zhang W, Peng D. Is recovery enhancement after gastric cancer surgery really a safe approach for elderly patients? World J Gastrointest Oncol. 2024;16:1334-1343. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Reference Citation Analysis (0)] |